Drug to treat prostate cancer shows promise
A single drug compound attacks prostate cancer by triggering immune cells and hinders the tumor's ability to use testosterone as fuel, a new study finds. The drug could be used to treat other solid tumors that don't respond to standard therapy. Read More
Omicron subvariants dodge neutralizing antibodies: study
Three subvariants of SARS-CoV-2 currently sweeping through the U.S. are better at evading vaccine- and infection-generating neutralizing antibodies than earlier versions of the virus, new research finds. Read More
Mitochondria seen as common thread in autism spectrum disorder
Researchers in Canada have discovered previously unknown connections between genetic factors in autism spectrum disorder, specifically with the mitochondria. Read More
Certain protein creates domino effect to set off ALS
King's College London researchers have found that the loss of a processing protein is likely the molecular trigger in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Read More
Scientists offer way to overcome barriers to nucleic acid delivery
Scientists from Australia's Monash University have suggested ways of overcoming the challenges in delivering nucleic acid therapeutics, including engineering smart, responsive, and targeted nanoparticle delivery systems. Read More
Sartorius BIA Separations, Exopharm team for large-scale exosome production
Bio-chromatography company Sartorius BIA Separations and medicine biopharmaceutical company Exopharm have signed a material transfer agreement in order to meet the demand of improved large-scale therapeutic exosome production and commercialization. Read More
New protein target may help fight COVID-19
A University of Geneva-led research team revealed a hidden cavity on the surface of a key non-structural SARS-CoV-2 protein. Their research, published November 22 in the journal eLife, may facilitate this cavity’s use as a target for binding therapeutic drugs. Read More
'Immunologic memory' may explain chronic inflammation in HIV: study
A study by researchers from George Washington University may explain why chronic inflammation occurs in people living with HIV and how suppression or even eradication of the virus may not resolve it. Read More
Sequencing project explores euglenoids' biotech potential
The Euglena International Network has launched a plan to sequence the genomes of all known euglenoid species over the next decade. Read More
Researchers discover way to increase synthetic mRNA's protein production
A team of researchers from the Hong Kong University of Science and Technology has discovered a way to increase synthetic mRNA's protein production efficiency by up to 10 times. They contend that their findings can improve the effectiveness of mRNA vaccines and drugs with even less dosage of the mRNAs. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
